Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aspen To Acquire Merck Assets | Contract Pharma

What are you searching for?

Sign in
Breaking News

Aspen To Acquire Merck Assets

To include API business in the Netherlands and 11 drug brands

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aspen Pharmacare, a generic drug company based in Johannesburg, plans to acquire drug assets and a plant from Merck in a transaction valued at approximately $1 billion. The transaction would include an API business in the Netherlands and a portfolio of 11 Merck drug brands, expanding Aspen’s presence in Europe, Latin America and Asia. According to a statement by Aspen, the deal is subject to the approval of various competition authorities and the South African Reserve Bank.
 
The company also announced plans to acquire the Arixtra and Fraxiparine/Fraxodi brands of thrombosis drugs from GlaxoSmithKline, except in China, Pakistan and India, in a transaction also valued at $1 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters